A presentation to be given next week at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) will suggest that men initially diagnosed with localized prostate cancer and who take an anti-clotting agent are at significantly lower risk for prostate cancer-specific death at 10 years of follow-up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anti-clotting agent, aspirin, prostate cancer-specific mortality, risk | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 